Lyell Immunopharma, Inc.

Q2 2025 13F Holders

Symbol
LYEL
CUSIP
55083R104
Type
Equity
Class
COM
Num filings
6
Total reported value, excl. options
$21.6 M
Manager Report Date Value ($000) Shares Option Type